These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1248 related articles for article (PubMed ID: 8366922)

  • 21. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Diabetes Control and Complications Trial: new challenges for the primary physician.
    Clarke WL
    Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.
    Reichard P; Berglund B; Britz A; Cars I; Nilsson BY; Rosenqvist U
    J Intern Med; 1991 Aug; 230(2):101-8. PubMed ID: 1865159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
    Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of the Diabetes Control and Complications Trial. American Diabetes Association.
    Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694
    [No Abstract]   [Full Text] [Related]  

  • 29. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
    Gæde P; Oellgaard J; Carstensen B; Rossing P; Lund-Andersen H; Parving HH; Pedersen O
    Diabetologia; 2016 Nov; 59(11):2298-2307. PubMed ID: 27531506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].
    Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J
    Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
    Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of long term complications in diabetes.
    Shield JP; Baum JD
    Arch Dis Child; 1994 Apr; 70(4):258-9. PubMed ID: 8185356
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
    The Diabetes Control and Complications Trial Research Group
    Diabetologia; 1998 Apr; 41(4):416-23. PubMed ID: 9562345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinopathy as a predictor of other diabetic complications.
    El-Asrar AM; Al-Rubeaan KA; Al-Amro SA; Moharram OA; Kangave D
    Int Ophthalmol; 2001; 24(1):1-11. PubMed ID: 11998880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy.
    Reichard P; Rosenqvist U
    J Intern Med; 1989 Aug; 226(2):81-7. PubMed ID: 2671247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood glucose self-monitoring in intensified insulin therapy: acceptance of frequent measurements and effect on quality of diabetic control].
    Weitgasser R; Schnöll F; Pretsch I; Gruber U; Sailer S
    Acta Med Austriaca; 1998; 25(2):61-4. PubMed ID: 9681045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of strict control on diabetic complications.
    Hanssen KF; Dahl-Jørgensen K; Brinchmann-Hansen O
    Acta Endocrinol Suppl (Copenh); 1985; 272():57-60. PubMed ID: 3914805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial.
    Kroc Collaborative Study Group
    N Engl J Med; 1984 Aug; 311(6):365-72. PubMed ID: 6377076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.